Published in Br J Pharmacol on June 01, 1977
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
Effect of drugs on the tryptamine content of rat tissues. J Pharmacol Exp Ther (1973) 0.97
Relationship of brain monoamine and locomotor activity in rats. Biochem Pharmacol (1975) 0.96
Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions. J Neurochem (1975) 0.91
Effects of lesions and drugs on brain tryptamine. J Neurochem (1974) 0.89
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev (1975) 1.79
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem (1983) 1.60
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacology (Berl) (2011) 1.44
Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function. J Neurochem (1998) 1.43
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol (2003) 1.22
Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol (2006) 1.19
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology (2003) 1.17
Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav (1998) 1.15
Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release. Life Sci (1978) 1.15
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) (2000) 1.09
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav (1991) 1.08
Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation. J Neurosci Methods (1995) 1.08
Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav (1992) 1.07
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology (1999) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci (2006) 1.05
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Social isolation increases aggressive behaviour and alters the effects of diazepam in the rat social interaction test. Behav Brain Res (1996) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology (2001) 0.99
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol (1999) 0.98
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci (2004) 0.97
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism. Neuropharmacology (2004) 0.97
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings]. Br J Pharmacol (1978) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Effects of chronic modification of dietary fat and carbohydrate in rats. Biochem J (1981) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
Inhibitors of caeruloplasmin. Biochem J (1967) 0.94
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med (1974) 0.93
Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.93
Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol (1987) 0.93
Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res (1991) 0.93
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem (1976) 0.93
Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions. J Neurochem (1974) 0.93
Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Br J Pharmacol (1986) 0.93
5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (1987) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol (1980) 0.92
The biochemistry of dyskinesias. Int Rev Neurobiol (1967) 0.92
Alterations in core body temperature, locomotor activity, and corticosterone following acute and repeated social defeat of male NMRI mice. Physiol Behav (2001) 0.92
Central c-fos expression following 20kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull (1997) 0.92
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl) (1992) 0.92
Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) (2005) 0.91
A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul Pept (1984) 0.91
A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem (1978) 0.91
Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology (Berl) (1983) 0.91
Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) (2003) 0.91
Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) (2005) 0.90
Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo. Neuroscience (1995) 0.90
Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol (1991) 0.90
Tryptophan metabolism in depression. J Neurol Neurosurg Psychiatry (1970) 0.90
Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol (2001) 0.90
Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology (1983) 0.90
Feeding rats on diets rich in fat need not alter the concentrations of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain. Biochem J (1982) 0.90
The biochemistry of the basal ganglia and Parkinson's disease. Postgrad Med J (1977) 0.90